000 01016 a2200289 4500
005 20250513063459.0
264 0 _c19940602
008 199406s 0 0 eng d
022 _a1047-2797
024 7 _a10.1016/1047-2797(93)90118-n
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHennekens, C H
245 0 0 _aAntiplatelet therapy and risk of stroke.
_h[electronic resource]
260 _bAnnals of epidemiology
_cSep 1993
300 _a568-70 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aCerebrovascular Disorders
_xprevention & control
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
_xprevention & control
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aRisk Factors
700 1 _aJonas, M A
700 1 _aBuring, J E
773 0 _tAnnals of epidemiology
_gvol. 3
_gno. 5
_gp. 568-70
856 4 0 _uhttps://doi.org/10.1016/1047-2797(93)90118-n
_zAvailable from publisher's website
999 _c8167158
_d8167158